Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XRNT Mechanism in Opioid Dependence
NCT01471145Phase 4Completed
- Sponsor
- University of Amsterdam
- Start
- Jan 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of naltrexone in heroin dependence (2 arms), sponsored by University of Amsterdam. Primary endpoint: Brain functions (fMRI and SPECT) at 3 months. Started Jan 2013; status: completed.
02
Drugs
naltrexone
03
Conditions
heroin dependence
Beyond the preview
Go deeper on NCT01471145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471145.